ghk-cu safety clinical studies Side Effects: What Does the Research Say? Doctor Explains GHK-Cu Peptide Injection Before and
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 234.stlund MP, Backman O, Marsk R, Stockeld D, Lagergren J, Rasmussen F, Nslund E

Key Takeaways GHK-Cu has a plasma half-life of approximately 30 minutes following subcutaneous injection, with serum levels dropping below detection within 68 hours

First characterised by Professor Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, BPC-157 has since become one of the most widely studied peptides in preclinical research, spanning gastrointestinal biology, musculoskeletal repair, neuroprotection, and cytoprotective signalling
How they work

Store at room temperature (15-30C) and protect from direct light

Alcohol in the body
